Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:03 AM EDT
159.00quote price arrow down-0.87 (-0.54%)
Volume
1,418
Close
159.87quote price arrow down-0.16 (-0.10%)
Volume
9,772,371
52 week range
33.72 - 189.26

...

Loading . . .
  • Open159.00
  • Day High163.58
  • Day Low155.23
  • Prev Close159.87
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low33.72
  • 52 Week Low Date04/15/20

Key Stats

  • Market Cap63.977B
  • Shares Out400.18M
  • 10 Day Average Volume8.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change53.03

KEY STATS

  • Open159.00
  • Day High163.58
  • Day Low155.23
  • Prev Close159.87
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low33.72
  • 52 Week Low Date04/15/20
  • Market Cap63.977B
  • Shares Out400.18M
  • 10 Day Average Volume8.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change53.03

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-82.53
  • Fwd P/E (NTM)7.44
  • EBITDA (MRQ)-731.893M
  • ROE (MRQ)-39.99%
  • Revenue (MRQ)803.40M
  • Gross Margin (MRQ)70.05%
  • Net Margin (MRQ)-92.99%
  • Debt To Equity (MRQ)5.24%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO0:3400:34
Moderna: Data shows Covid vaccine 90% effective after six months

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
401.96+3.89+0.98%
BNTX
BioNTech SE
140.72+8.12+6.12%
GMAB
Genmab A/S
34.98+0.31+0.89%
SGEN
Seagen Inc
149.64+5.44+3.77%
EXAS
Exact Sciences Corp
130.52+3.38+2.66%